Short description
Ervaccine Technologies is a biotechnology company that develops cancer vaccines and T cell-based immunotherapies.
Description
ErVaccine Technologies creates immunotherapies that integrate T-cell treatments with cancer vaccinations to meet a medical need for cold tumors. They are committed to identifying tumor epitopes that are physician. They come from endogenous retroviruses and are novel cancer epitopes. They use a bioinformatics-based strategy to find possible epitopes, which are then verified by proteomics and immunological testing.
Last funding
Blurry Noaccess
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Lyon, Rhone-Alpes, France, Europe
Founded on
January 10, 2019
Non-profit?
No
Acquired?
No
Employees count
1-10
Investors
Noaccess, Blurry Noaccess
Sign in for full access
Founders
Stéphane Depil